1. Home
  2. ENTA vs RM Comparison

ENTA vs RM Comparison

Compare ENTA & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$12.12

Market Cap

374.6M

Sector

Health Care

ML Signal

N/A

Logo Regional Management Corp.

RM

Regional Management Corp.

N/A

Current Price

$32.78

Market Cap

390.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
RM
Founded
1995
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
390.4M
IPO Year
2012
2011

Fundamental Metrics

Financial Performance
Metric
ENTA
RM
Price
$12.12
$32.78
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$20.40
$30.00
AVG Volume (30 Days)
147.1K
33.0K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
3.70%
EPS Growth
29.93
7.49
EPS
N/A
4.45
Revenue
$102,814,000.00
$645,598,000.00
Revenue This Year
$7.76
$12.78
Revenue Next Year
N/A
$8.78
P/E Ratio
N/A
$7.30
Revenue Growth
16.48
9.70
52 Week Low
$4.09
$25.41
52 Week High
$17.15
$46.00

Technical Indicators

Market Signals
Indicator
ENTA
RM
Relative Strength Index (RSI) 39.11 50.53
Support Level $12.09 $30.65
Resistance Level $15.52 $35.24
Average True Range (ATR) 0.63 1.08
MACD -0.17 0.28
Stochastic Oscillator 7.62 90.80

Price Performance

Historical Comparison
ENTA
RM

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

Share on Social Networks: